Company Overview of Flagship Ventures
Flagship Ventures is a venture capital firm specializing in incubation, seed stage, early, later and growth stage investments. The firm prefers to invest in the healthcare including biotherapeutics, life sciences, medical technologies, biological discoveries leading to new therapies, advanced analysis for improved medicine, chemistries and small molecule drugs, nanotechnology for medicine; energy efficiency; bioenergy; sustainability; and cleantechnology sector. The firm seeks to invest in Midwest. It seeks to initially invest between $500,000 and $5 million, with a typical investment between $7 million and $15 million as part of a syndicate in its portfolio companies. The firm typically mak...
One Memorial Drive
Cambridge, MA 02142
Founded in 2000
Key Executives for Flagship Ventures
Co-Founder, Senior Managing Partner, and Chief Executive Officer
Co-Founder and Managing Partner
Chief Operating Officer, Partner, and General Partner
Partner and Chief Business Officer
Compensation as of Fiscal Year 2015.
Flagship Ventures Key Developments
Flagship Ventures Presents at HighQuest Partners, LLC's 7th Annual Global AgInvesting Conference, Apr-30-2015 09:00 AM
Apr 24 15
Flagship Ventures Presents at HighQuest Partners, LLC's 7th Annual Global AgInvesting Conference, Apr-30-2015 09:00 AM. Venue: Waldorf Astoria, 301 Park Avenue, New York, NY 10022, United States. Speakers: Ignacio Martinez, Partner.
Flagship Ventures Presents at Boston CEO Conference, May-27-2015 10:50 AM
Apr 16 15
Flagship Ventures Presents at Boston CEO Conference, May-27-2015 10:50 AM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: David A. Berry, General Partner.
Flagship Ventures Announces Executive Promotions
Mar 26 15
Flagship Ventures announced that Douglas Cole, M.D., has been promoted to managing partner and David Berry, M.D. Ph.D., has been promoted to general partner. Dr. Cole has led investments in Agios Pharmaceuticals, CombinatoRx (ZLCS), Concert Pharmaceuticals (CNCE), Editas Medicine, Receptos, Quanterix, Syros Pharmaceuticals and Tetraphase Pharmaceuticals. Dr. Berry has led several investments and is a co-founder of portfolio companies Joule Unlimited, Eleven Biotherapeutics (EBIO), Seres Health, and Pronutria Biosciences.
Similar Private Companies By Industry
Recent Private Companies Transactions